Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.23750/abm.v91i3.9849 http://scihub22266oqcxt.onion/10.23750/abm.v91i3.9849 32921719!7716949!32921719     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32921719&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Acta+Biomed 2020 ; 91 (3): e2020022 Nephropedia Template TP {{tp|p=32921719|t=2020. Implications of Telemedicine in Oncology during the COVID-19 Pandemic |pdf=|usr=}}{{32921719}} gab.com Text Implications of Telemedicine in Oncology during the COVID-19 Pandemic JO: Acta Biomed http://www.kidney.de/pget.php?&tw=1&pmid=32921719 #FOAvip COVID-19 has had a catastrophic effect on healthcare systems compromising the treatment of cancer patients. It has an increased disease burden in the cancer population. As a result, tele-oncology services have become essential to reduce the risk of cancer patients being exposed to the deadly pathogen. Many governmental establishments have endorsed the use of tele-oncology during COVID-19 era. However, telemedicine in oncology still has certain drawbacks that can be improved upon. Nevertheless, tele-oncology has shown great promise to support cancer care not only during this pandemic but also become a part of normal care in the future. Twit Text FOAVip Implications of Telemedicine in Oncology during the COVID-19 Pandemic ????Acta Biomed http://www.kidney.de/pget.php?&tw=1&pmid=32921719 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32921719 #FOAvip English Wikipedia <ref>{{Cite pmid|32921719}}</ref> Implications of Telemedicine in Oncology during the COVID-19 Pandemic #MMPMID32921719 Shirke MM; Shaikh SA; Harky A Acta Biomed 2020[Sep]; 91 (3): e2020022 PMID32921719show ga COVID-19 has had a catastrophic effect on healthcare systems compromising the treatment of cancer patients. It has an increased disease burden in the cancer population. As a result, tele-oncology services have become essential to reduce the risk of cancer patients being exposed to the deadly pathogen. Many governmental establishments have endorsed the use of tele-oncology during COVID-19 era. However, telemedicine in oncology still has certain drawbacks that can be improved upon. Nevertheless, tele-oncology has shown great promise to support cancer care not only during this pandemic but also become a part of normal care in the future. |*Betacoronavirus[MESH] |*Medical Oncology[MESH] |*Pandemics[MESH] |COVID-19[MESH] |Combined Modality Therapy[MESH] |Comorbidity/trends[MESH] |Coronavirus Infections/*epidemiology[MESH] |Delivery of Health Care/*methods[MESH] |Humans[MESH] |Neoplasms/*epidemiology/therapy[MESH] |Pneumonia, Viral/*epidemiology[MESH] |SARS-CoV-2[MESH]Implications of Telemedicine in Oncology during the COVID-19 Pandemic (epmc).pdf DeepDyve Pubget Overpricing